Cac 40 Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cac 40 stocks.

Cac 40 Stocks Recent News

Date Stock Title
Nov 21 MRK Merck & Co., Inc. (MRK) Jefferies London Healthcare Conference
Nov 21 MRK Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
Nov 21 MRK Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals
Nov 21 MT This Little-Known Metal Just Exploded 200%, Here are 2 Ways To Play It
Nov 20 SNY CDC warns of an imminent spike in COVID, flu cases
Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
Nov 20 SNY Here’s What Drove Sanofi’s (SNY) Earnings
Nov 20 MT Steelworkers at two ArcelorMittal plants in France go on strike over potential closures
Nov 20 SNY Sanofi: Information concerning the total number of voting rights and shares - October 2024
Nov 20 TTE TotalEnergies SE Announces Final Results of Its Tender Offer in Respect of Its €2,500,000,000 Undated Deeply Subordinated Fixed Rate Resettable Notes With a First Call Date on 26 February 2025
Nov 20 TTE Top Three Dividend Stocks To Enhance Your Portfolio
Nov 19 MRK Merck readies new Keytruda version ahead of major regulatory headwinds
Nov 19 MRK Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
Nov 19 MRK Merck raises dividend to $0.81/share
Nov 19 MRK Merck Announces First-Quarter 2025 Dividend
Nov 19 EQH Equitable Holdings Rises 4.7% Since Q3 Beat on Strong Asset Management
Nov 19 MRK Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Nov 19 MRK Merck says injectable Keytruda succeeded in late-stage trial
Nov 19 MRK Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says
Cac 40

The CAC 40 (Cotation Assistée en Continu) is a benchmark French stock market index. It is composed of the 40 most actively traded stocks on the Euronext Paris exchange. The index is free-float adjusted, meaning that the weighting of each company is based on the number of shares available to the public. The CAC 40 is seen as a good indicator of the overall performance of the French economy.

Browse All Tags